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bial properties. As an illustration of their potential utility,Plumbing New Depths
approximately half of all current anticancer discoveryin Drug Discovery efforts are focused on marine organisms [3].
Exploiting the chemical diversity of marine metabo-
lites, however, has been greatly hampered by their ex-
tremely low natural abundance. In addition, all but a
Marine natural products are an untapped source for small fraction of marine microbes are difficult to culture
drug development. In this month’s Chemistry & Biol- using conventional methods, particularly those that are
ogy, Gerwick and coworkers [1] describe the biosyn- symbionts of aquatic invertebrates [4]. One promising
thetic genes for novel neurotoxins, jamaicamides A–C alternative is to clone the biosynthetic genes and trans-
from Lyngbya majuscula, bringing closer the goal of fer them wholesale from the natural hosts to more pro-
producing marine natural products in terrestrial hosts. ductive alternatives. This strategy not only offers a more
secure source of these compounds, but also paves the
Following on the failure of combinatorial chemistry to way for the genetic engineering of unnatural variants of
deliver the anticipated wealth of new drug candidates, these molecules for use in drug discovery [5, 6]. How-
interest in natural products as pharmaceutical leads has ever, research in this area is relatively new, with only
been significantly rekindled [2]. One of the least charac- three complete gene clusters sequenced to date [7–9].
terized but most promising sources for new drug candi- From a “retrobiosynthetic” analysis, it appears that
dates is the ocean: to survive in this environment, it many marine metabolites are of polyketide or nonribo-
seems that microorganisms must produce a tremen- somal polypeptide origin, and a significant number in-
dous diversity of toxic metabolites [3]. Not only are these corporate features of both [4]. Assembly of such struc-
compounds cytotoxic, but many exhibit important me- tures in terrestrial microorganisms occurs on gigantic
dicinal activities including anticancer, antifungal, anti- multienzymes called polyketide synthases (PKSs) and
nonribosomal polypeptide synthases (NRPSs), respec-malarial, antiviral, immunosuppressive, and antimicro-
Chemistry & Biology
744
Figure 1. Organization of Modular Biosynthetic Systems
(A) Complement of domains in polyketide synthases (PKSs). Each PKS module minimally incorporates ketosynthase (KS), acyl transferase
(AT), and acyl carrier protein (ACP) domains, which cooperate in chain extension. Modules can also include optional reductive activities,
ketoreductase (KR), dehydratase (DH), and enoyl reductase, as well as methyl transferases (MT). Chain extension is typically terminated by
a thioesterase (TE) domain.
(B) Complement of domains in nonribosomal polypeptide synthetases (NRPSs). Each NRPS module minimally incorporates condensation (C),
adenylation (A), and peptidyl carrier protein (PCP) domains, which cooperate in chain extension. Modules can also include optional activities:
epimerization (E), cyclization (C), oxidoreductase (Ox), and methyl transferase (MT) domains. Chain extension is often terminated by a
thioesterase (TE) domain (figure adapted from [3]).
tively, which catalyze the sequential condensation of terrestrial microorganisms can be used to locate analo-
gous genes in marine strains; this is particularly the casesimple carboxylic acid (PKS) or amino acid (NRPS) build-
ing blocks into a growing chain [10]. The individual cata- for terrestrial microbes that make compounds similar or
identical to those from marine sources [4]. However,lytic domains within these enzymes are organized into
modules, where each module is typically responsible many marine natural products also possess functional
groups without terrestrial counterparts, and these struc-for a single round of chain extension and any necessary
modification reactions. Each module of a PKS minimally tural differences will undoubtedly be reflected in their
biosynthetic pathways. Therefore, identifying marinecontains a ketosynthase (KS) domain responsible for
carbon-carbon bond formation, an acyltransferase (AT) PKS and NRPS pathways could significantly expand
the “molecular toolbox” of genes used in the geneticdomain for building block selection, and an acyl carrier
protein (ACP) to which the growing chain is tethered engineering of new drugs.
Among marine microbes, cyanobacteria (blue-green(see Figure 1). The corresponding activities within the
NRPSs are the condensation (C), adenylation (A), and algae) have a proven track record as producers of novel,
biologically active compounds. The clear metabolic “su-peptidyl carrier protein (PCP) domains. In addition, mod-
ules in both pathways contain a variety of auxiliary do- perstar” is the tropical, filamentous cyanobacterium
Lyngbya majuscula, which biosynthesizes fully 30% ofmains, including reductive activities in the case of PKSs
and epimerases and cyclases in the case of NRPSs. In all natural products so far isolated from cyanobacteria
[3]. Analysis of the over 110 L. majuscula metabolitesmost systems, there is a dedicated domain for each
step in the biosynthesis, with the consequence that it characterized to date shows that an impressive 75%
have some sort of biological activity. While 58% of theseis often possible to deduce the complement of domains
in a PKS or NRPS from its product and visa versa. are lipopeptides of mixed polyketide-polypeptide origin,
many other structural classes are also represented, in-The underlying similarity between the marine and ter-
restrial pathways means that biosynthetic genes from cluding fatty acids, alkaloids, and pyrroles [3]. The meta-
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bolic richness of L. majuscula and its relative amenability Pleasingly, the deduced gene sequence suggests
to culturing in the laboratory makes it a model organism plausible mechanisms by which the alkynyl, vinyl, and
for developing genetic techniques applicable to cyano- pyrrolinone features are formed, although the timing and
bacteria and other marine microbes. mechanism of the critical halogenation reactions remain
In this issue of Chemistry & Biology, Gerwick and uncertain. For example, the pathway contains a candi-
coworkers report the isolation of yet more bioactive date “-modifying gene cassette” for vinyl group forma-
metabolites from L. majuscula—the novel lipopeptides tion similar to that observed in other PKS pathways,
jamaicamides A–C, which exhibit cytotoxicity toward such as mupirocin [11], and an NRPS condensation do-
cancer cells as well as sodium channel-blocking activity main homolog that may be involved in pyrrolinone ring
[1]. The jamaicamides have several notable structural formation. Although the goal of expressing the entire jam
features, including a rare alkynyl bromide, an unusually cluster in a heterologous host remains distant, specific
located vinyl chloride, and a terminal pyrrolinone func- genes from the pathway could have more immediate
tionality; the genes responsible for these functionalities value in attempts to create further structural diversity
are therefore very attractive targets for inclusion in an among polyketides and peptide natural products
engineering toolbox. Using feeding studies with isotopi- through genetic engineering.
cally labeled precursors, the authors were able to estab-
lish conclusively that the jamaicamides are of mixed
Kira Weissmanpolyketide-polypeptide origin. These experiments also
Department of Biochemistrysuggested the involvement of a 3-hydroxy-3-methylglu-
University of Cambridgetaryl-CoA synthase (HMGCS) in forming the vinyl chlo-
80 Tennis Court Roadride function [11].
Cambridge CB2 1GABased on this information, Gerwick and his colleagues
United Kingdomwere able to design specific probes for the PKS genes
of the jamaicamide pathway using conserved KS se-
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The central role of microtubules in the process of segre-Bending at Microtubule Interfaces
gating duplicated chromosomes before cell division
makes them an important target for antimitotic drugs.
Microtubules that make up the mitotic spindle are in a
delicate state of balance between assembly and disas-
sembly. This is important because both the formation
of the spindle and the movement of chromosomes toMicrotubule-destabilizing drugs alter the interfaces
opposite spindle poles depend on carefully coordinatedbetween subunits so that they cannot assemble into
extension or shrinkage at both ends of the microtubulesstraight filaments [1]. Most target -tubulin, but piro-
in the spindle. The protein subunits, -tubulin hetero-netin binds to the supposedly inactive  subunit [2].
dimers, together with two bound molecules of guano-This unusual drug binds covalently to lysine but is
nevertheless specific for -tubulin. sine triphosphate (GTP), assemble head to tail in a polar
